THE FUTURE OF PET MEDICINE
We are offering the following collaboration opportunities:
- Commercial partnerships in various geographies for the development of LS-001, polymer based LAI for the control of pain due to bone cancer in dogs, and LS-002, for control of pain in dogs due to pancreatitis.
- License our biodegradable polymer based LAI platform for delivery of a partner’s proprietary product.
- License our pipeline of early product candidates to address chronic conditions such as :
- Endocrine disorders